Published in Curr Eye Res on September 01, 1988
Topical Use of Corticosteroid to Prevent Epiretinal Membrane Following Retinal Tear | NCT02412059
Immunopathology of intraocular silicone oil: retina and epiretinal membranes. Br J Ophthalmol (2006) 0.99
Morphometric spectral-domain optical coherence tomography features of epiretinal membrane correlate with visual acuity in patients with uveitis. Am J Ophthalmol (2012) 0.97
Epiretinal membranes in patients with uveitis: morphological and functional analysis with spectral domain optical coherence tomography. Biomed Res Int (2013) 0.78
Inflammation and macular oedema after pars plana vitrectomy. Mediators Inflamm (2013) 0.78
Extraction of prostaglandins from human blood. Nature (1971) 4.37
Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery. Arch Ophthalmol (1994) 3.41
Prostaglandin E2 and gastric acid secretion in man. J Physiol (1973) 3.16
Missense mutations in COL8A2, the gene encoding the alpha2 chain of type VIII collagen, cause two forms of corneal endothelial dystrophy. Hum Mol Genet (2001) 3.06
Fit with finger block. Anaesth Intensive Care (1992) 2.66
Relationship between corneal thickness and measured intraocular pressure in a general ophthalmology clinic. Ophthalmology (1999) 2.48
Waiting times and the patient's charter. BMJ (1994) 1.99
Role of axoplasmic transport in the pathophysiology of ischaemic disc swelling. Br J Ophthalmol (1980) 1.98
Release of prostaglandins in ocular inflammation in the rabbit. Nat New Biol (1972) 1.97
The place of trabeculectomy in the treatment of glaucoma. Ophthalmology (1981) 1.91
Clinico pathological correlation in eyes with failed fistulizing surgery. Trans Ophthalmol Soc U K (1983) 1.90
Adverse effects of topical antiglaucoma medication. I. The conjunctival cell profile. Arch Ophthalmol (1994) 1.80
Ocular injuries from boxing. BMJ (1992) 1.79
Variation in epiretinal membrane components with clinical duration of the proliferative tissue. Br J Ophthalmol (1990) 1.71
The role of axoplasmic transport in the pathogenesis of retinal cotton-wool spots. Br J Ophthalmol (1977) 1.62
Expanded polytetrafluoroethylene as a substrate for retinal pigment epithelial cell growth and transplantation in age-related macular degeneration. Br J Ophthalmol (2011) 1.60
Ophthalmoscopic signs of obstructed axoplasmic transport after ocular vascular occlusions. Br J Ophthalmol (1976) 1.59
Long-term morphologic effects of antiglaucoma drugs on the conjunctiva and Tenon's capsule in glaucomatous patients. Ophthalmology (1989) 1.56
Retinal and epiretinal glia--an immunohistochemical study. Br J Ophthalmol (1984) 1.54
Targeting triple-negative breast cancer: optimising therapeutic outcomes. Ann Oncol (2012) 1.49
Immediate treatment with bicalutamide 150mg as adjuvant therapy significantly reduces the risk of PSA progression in early prostate cancer. Eur Urol (2003) 1.46
VEGF localisation in diabetic retinopathy. Br J Ophthalmol (1998) 1.40
Natural history of fibrocellular epiretinal membranes: a quantitative, autoradiographic, and immunohistochemical study. Br J Ophthalmol (1985) 1.38
Changes in the monkey outflow apparatus at graded levels of intraocular pressure: a qualitative analysis by light microscopy and scanning electron microscopy. Exp Eye Res (1974) 1.38
Matrix and the retinal pigment epithelium in proliferative retinal disease. Prog Retin Eye Res (1999) 1.38
Retinal pigment epithelial cells in epiretinal membranes: an immunohistochemical study. Br J Ophthalmol (1984) 1.38
D-ACE surgical sequence for selected bullous retinal detachments. Br J Ophthalmol (1985) 1.37
Deriving temperature and age appropriate heart rate centiles for children with acute infections. Arch Dis Child (2008) 1.35
Indentation microsurgery: internal searching for retinal breaks. Eye (Lond) (1989) 1.32
Prolonged localized tissue effects from 5-minute exposures to fluorouracil and mitomycin C. Arch Ophthalmol (1993) 1.31
Racial differences in the results of glaucoma filtration surgery: are racial differences in the conjunctival cell profile important? Br J Ophthalmol (1994) 1.29
The long-term effects of 5-fluorouracil and sodium butyrate on human Tenon's fibroblasts. Invest Ophthalmol Vis Sci (1992) 1.29
Rapid B-scanning of the vitreous. Br J Ophthalmol (1977) 1.28
Clinical sign of obstructed axoplasmic transport. Lancet (1975) 1.26
Management of complex retinal detachments by vitrectomy and fluid/silicone exchange. Trans Ophthalmol Soc U K (1982) 1.26
Ultrastructure of the trabecular meshwork in untreated cases of primary open-angle glaucoma (POAG). Exp Eye Res (1993) 1.26
Histopathologic and clinical associations of scleritis and glaucoma. Am J Ophthalmol (1981) 1.24
Adverse effects of topical antiglaucomatous medications on the conjunctiva. Br J Ophthalmol (1993) 1.23
Partial central retinal artery occlusion. Trans Ophthalmol Soc U K (1978) 1.22
Coats' disease of the retina (unilateral retinal telangiectasis) caused by somatic mutation in the NDP gene: a role for norrin in retinal angiogenesis. Hum Mol Genet (1999) 1.22
Massive proliferation of lens epithelial remnants after Nd-YAG laser capsulotomy. Br J Ophthalmol (1995) 1.20
Improved purification and chromatography of extracts containing prostaglandins. J Physiol (1972) 1.20
Pressure-induced changes in the ultrastructure of the endothelium lining Schlemm's canal. Am J Ophthalmol (1975) 1.20
Late onset vitreoretinal complications of regressed retinopathy of prematurity. Br J Ophthalmol (2004) 1.16
Activation and suppression of fibroblast function. Eye (Lond) (1994) 1.15
Increased expression of placenta growth factor in proliferative diabetic retinopathy. Lab Invest (1998) 1.15
Prostaglandins as mediators for the responses of the eye to trauma. Exp Eye Res (1973) 1.14
A simple organ culture model for assessing the effects of growth factors on corneal re-epithelialization. Exp Eye Res (1996) 1.13
Vasoproliferative retinopathies: clinical, morphogenetic and modulatory aspects. Eye (Lond) (1988) 1.13
Edible mushroom (Agaricus bisporus) lectin, which reversibly inhibits epithelial cell proliferation, blocks nuclear localization sequence-dependent nuclear protein import. J Biol Chem (1999) 1.12
Local effects of previous conjunctival incisional surgery and the subsequent outcome of filtration surgery. Am J Ophthalmol (1998) 1.12
Cytokeratin-containing cells in proliferative diabetic retinopathy membranes. Br J Ophthalmol (1994) 1.11
Results of closed vitrectomy. Trans Ophthalmol Soc U K (1977) 1.11
Effects of pilocarpine on the morphology of the human outflow apparatus. Br J Ophthalmol (1978) 1.10
Identification in vitreous and molecular cloning of opticin, a novel member of the family of leucine-rich repeat proteins of the extracellular matrix. J Biol Chem (2000) 1.10
Scanning laser tomography Z profile signal width as an objective index of macular retinal thickening. Br J Ophthalmol (1998) 1.10
Proliferative vitreoretinopathy. Lymphocytes in epiretinal membranes. Ophthalmology (1992) 1.10
Entry site neovascularisation after diabetic vitrectomy. Br J Ophthalmol (2000) 1.09
Taxol in advanced, hormone-refractory carcinoma of the prostate. A phase II trial of the Eastern Cooperative Oncology Group. Cancer (1993) 1.08
Distribution and origin of calcitonin gene-related peptide (CGRP) immunoreactivity in the sensory innervation of the mammalian eye. J Comp Neurol (1985) 1.08
Growth factor staining patterns in the pig retina following retinal laser photocoagulation. Br J Ophthalmol (1999) 1.08
Cilio-retinal infarction after retinal vein occlusion. Br J Ophthalmol (1976) 1.07
Suture needle drainage of subretinal fluid. Br J Ophthalmol (1993) 1.07
Influence of laser photocoagulation for clinically significant diabetic macular oedema (DMO) on short-wavelength and conventional automated perimetry. Diabetologia (1998) 1.07
Epiretinal membranes in vitro. Trans Ophthalmol Soc U K (1983) 1.07
Monitored posterior transcleral drainage of subretinal fluid. Br J Ophthalmol (1985) 1.06
Pars plana vitrectomy for vitreous amyloidosis. Ophthalmology (1987) 1.05
Reversal of topical antiglaucoma medication effects on the conjunctiva. Arch Ophthalmol (1996) 1.05
Inflammatory cells in proliferative vitreoretinopathy subretinal membranes. Ophthalmology (1993) 1.05
Immunolocalisation of the VEGF receptors FLT-1, KDR, and FLT-4 in diabetic retinopathy. Br J Ophthalmol (1999) 1.05
Pathobiology of epiretinal and subretinal membranes: possible roles for the matricellular proteins thrombospondin 1 and osteonectin (SPARC). Eye (Lond) (2002) 1.05
Vitrectomy and fluid/silicone-oil exchange for giant retinal tears: results at six months. Br J Ophthalmol (1984) 1.05
Intravitreal growth factors in proliferative diabetic retinopathy: correlation with neovascular activity and glycaemic management. Br J Ophthalmol (1997) 1.04
Challenges in ophthalmic pathology: the vitreoretinal membrane biopsy. Eye (Lond) (2000) 1.04
Wound healing in an animal model of glaucoma fistulizing surgery in the rabbit. Ophthalmic Surg (1989) 1.03
Three dimensional analysis of microaneurysms in the human diabetic retina. J Anat (1999) 1.03
Biomaterials used in the posterior segment of the eye. Biomaterials (2000) 1.02
Topical analgesia for superficial corneal injuries. J Accid Emerg Med (1996) 1.02
Elevated plasma CD105 and vitreous VEGF levels in diabetic retinopathy. J Cell Mol Med (2005) 1.02
Light microscopic quantitation of the endothelial vacuoles in Schlemm's canal. Am J Ophthalmol (1977) 1.02
Inflammation and the formation of epiretinal membranes. Eye (Lond) (1988) 1.02
The response of the rabbit eye to laser irradiation of the iris. Exp Eye Res (1974) 1.01
Three dimensional analysis of the retinal vasculature using immunofluorescent staining and confocal laser scanning microscopy. Br J Ophthalmol (1996) 1.01
Evaluation of CancerChatCanada: a program of online support for Canadians affected by cancer. Curr Oncol (2013) 1.01
Morphological effects of argon laser trabeculoplasty upon the glaucomatous human meshwork. Eye (Lond) (1989) 1.01
Acid mucopolysaccharides in the outflow apparatus. Exp Eye Res (1975) 1.01
The cytoskeletal elements of human retinal pigment epithelium: in vitro and in vivo. J Cell Sci (1988) 1.00
Age-related cellular proliferation at the vitreoretinal juncture. Eye (Lond) (1987) 1.00
Major depression and cardiac autonomic control. Biol Psychiatry (1997) 1.00
Retinal ischaemia, disc swelling, and axoplasmic transport. Trans Ophthalmol Soc U K (1976) 1.00
Prolongation of rat corneal graft survival by treatment with anti-CD4 monoclonal antibody. Br J Ophthalmol (1992) 1.00
The fine structure of the trabecular meshwork at graded levels of intraocular pressure. (1) Pressure effects within the near-physiological range (8-30 mmHg). Exp Eye Res (1975) 1.00
Long-term follow-up of drusen-like lesions in patients with type II mesangiocapillary glomerulonephritis. Br J Ophthalmol (2008) 0.99
Erythrocyte phagocytosis in the human trabecular meshwork. Br J Ophthalmol (1973) 0.99